Focus will be on new information that needs to be included in informed consent materials for clinical trials
Company focuses on energizing and empowering investigative sites that support clinical research Princeton, NJ – April 12, 2019 – The WIRB-Copernicus Group® (WCG™) is pleased to announce the addition of several prominent executives to its Site Division and the expansion of its Global Research Network™ (GRN) of investigative sites. WCG is the leader in supporting […]
Company to highlight expanded focus on investigative sites at Annual Meeting of the Association of Clinical Research Professionals (ACRP) Princeton, NJ – April 10, 2019 – The WIRB-Copernicus Group’s® (WCG™) Site Division is pleased to announce its participation in the Annual Meeting of the Association of Clinical Research Professionals (ACRP) on April 12-15, 2019 in […]
WCG welcomes leading provider of solutions that improve the quality of clinical trials in pain management Princeton, NJ – April 4, 2019 – The WIRB-Copernicus Group®’s (WCG™) Clinical Services Division announces the acquisition of Analgesic Solutions, LLC, the global leader in the development of new pain medications and in the support of clinical trials in […]
WCG SiteReady™ helps institutions and independent sites optimize their participation in clinical research Princeton, NJ – March 19, 2019 –WIRB-Copernicus Group® (WCG™) introduces WCG SiteReady™, a first-of-its-kind solution aimed at increasing the efficiency and profitability of clinical research for institutions and independent research sites. WCG’s newest offering helps researchers to optimize their performance, gain a competitive […]
Top global consultancy teams with leading pharmacovigilance service provider to deliver seamless suite of safety solutions to accelerate clinical research.
Eight internationally recognized subject matter experts join company to advise clients, inform strategy and support delivery of technology-enabled solutions
WCG Expert to Lead Human Gene Transfer Educational Course at the ABSA Annual Biological Safety Conference
Course will cover the latest applications of synthetic biology in clinical research and help IBC members prepare to review gene therapy protocols.